Vera Therapeutics, Inc. Earnings Per Share (Basic)
Vera Therapeutics, Inc. (VERA) reported Earnings Per Share (Basic) of -$1.52 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-10
- Vera Therapeutics, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$1.52.
- Vera Therapeutics, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$1.69.
- Vera Therapeutics, Inc. earnings per share, basic for the quarter ending 2025-12-31 was -$1.39.
- Vera Therapeutics, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$1.26.
- Vera Therapeutics, Inc. earnings per share, basic for fiscal 2025 was -$4.66.
- Vera Therapeutics, Inc. earnings per share, basic for fiscal 2024 was -$2.75.
- Vera Therapeutics, Inc. earnings per share, basic for fiscal 2023 was -$2.25.
- Vera Therapeutics, Inc. earnings per share, basic for fiscal 2022 was -$3.35.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.52 10-Q · filed 2026-08-10 | -$3.22 10-Q · filed 2026-08-10 | -$4.62 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$5.89 derived: net income ÷ weighted average shares · filed 2026-08-10 |
| 2026-03-31 | -$1.69 10-Q · filed 2026-05-07 | -$3.09 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$4.37 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$5.57 derived: net income ÷ weighted average shares · filed 2026-08-10 |
| 2025-12-31 | -$1.39 derived: net income ÷ weighted average shares · filed 2026-04-09 | -$2.65 derived: net income ÷ weighted average shares · filed 2026-04-09 | -$3.85 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$4.66 10-K · filed 2026-02-26 |
| 2025-09-30 | -$1.26 10-Q · filed 2025-11-05 | -$2.46 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$3.27 10-Q · filed 2025-11-05 | -$4.00 derived: net income ÷ weighted average shares · filed 2026-08-10 |
| 2025-06-30 | -$1.20 10-Q · filed 2026-08-10 | -$2.01 10-Q · filed 2026-08-10 | -$2.74 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$3.59 derived: net income ÷ weighted average shares · filed 2026-08-10 |
| 2025-03-31 | -$0.81 10-Q · filed 2026-05-07 | -$1.53 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$2.37 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$3.00 derived: net income ÷ weighted average shares · filed 2026-08-10 |
| 2024-12-31 | -$0.72 derived: net income ÷ weighted average shares · filed 2026-04-09 | -$1.56 derived: net income ÷ weighted average shares · filed 2026-04-09 | -$2.18 derived: net income ÷ weighted average shares · filed 2026-04-09 | -$2.75 10-K · filed 2026-02-26 |
| 2024-09-30 | -$0.85 10-Q · filed 2025-11-05 | -$1.47 derived: net income ÷ weighted average shares · filed 2025-11-05 | -$2.03 10-Q · filed 2025-11-05 | -$2.62 derived: net income ÷ weighted average shares · filed 2026-04-09 |
| 2024-06-30 | -$0.62 10-Q · filed 2025-08-05 | -$1.17 10-Q · filed 2025-08-05 | -$1.75 derived: net income ÷ weighted average shares · filed 2026-04-09 | -$2.22 derived: net income ÷ weighted average shares · filed 2026-04-09 |
| 2024-03-31 | -$0.56 10-Q · filed 2025-05-07 | -$1.13 derived: net income ÷ weighted average shares · filed 2026-04-09 | -$1.59 derived: net income ÷ weighted average shares · filed 2026-04-09 | -$2.05 derived: net income ÷ weighted average shares · filed 2026-04-09 |
| 2023-12-31 | -$0.58 derived: net income ÷ weighted average shares · filed 2026-04-09 | -$1.03 derived: net income ÷ weighted average shares · filed 2026-04-09 | -$1.49 derived: net income ÷ weighted average shares · filed 2026-04-09 | -$2.25 10-K · filed 2026-02-26 |
| 2023-09-30 | -$0.45 10-Q · filed 2024-11-07 | -$0.91 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$1.67 10-Q · filed 2024-11-07 | -$2.67 derived: net income ÷ weighted average shares · filed 2024-11-07 |
| 2023-06-30 | -$0.46 10-Q · filed 2024-08-08 | -$1.23 10-Q · filed 2024-08-08 | -$2.26 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$3.14 derived: net income ÷ weighted average shares · filed 2024-11-07 |
| 2023-03-31 | -$0.80 10-Q · filed 2024-05-10 | -$1.91 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$2.82 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$3.41 derived: net income ÷ weighted average shares · filed 2024-11-07 |
| 2022-12-31 | -$1.17 derived: net income ÷ weighted average shares · filed 2024-03-27 | -$2.08 derived: net income ÷ weighted average shares · filed 2024-03-27 | -$2.63 derived: net income ÷ weighted average shares · filed 2024-03-27 | -$3.35 10-K · filed 2024-03-27 |
| 2022-09-30 | -$0.91 10-Q · filed 2023-11-09 | -$1.46 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$2.16 10-Q · filed 2023-11-09 | -$2.94 derived: net income ÷ weighted average shares · filed 2023-11-09 |
| 2022-06-30 | -$0.55 10-Q · filed 2023-08-10 | -$1.24 10-Q · filed 2023-08-10 | -$2.01 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$2.40 derived: net income ÷ weighted average shares · filed 2023-11-09 |
| 2022-03-31 | -$0.71 10-Q · filed 2023-05-11 | -$1.49 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$1.86 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$2.33 derived: net income ÷ weighted average shares · filed 2023-11-09 |
| 2021-12-31 | -$0.79 derived: net income ÷ weighted average shares · filed 2023-03-28 | -$1.15 derived: net income ÷ weighted average shares · filed 2023-03-28 | -$1.58 derived: net income ÷ weighted average shares · filed 2023-03-28 | -$2.43 10-K · filed 2023-03-28 |
| 2021-09-30 | -$0.36 10-Q · filed 2022-11-09 | -$0.70 derived: net income ÷ weighted average shares · filed 2022-11-09 | -$1.46 10-Q · filed 2022-11-09 | |
| 2021-06-30 | -$0.33 10-Q · filed 2022-08-10 | -$1.49 10-Q · filed 2022-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |